Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1992-12-18
1997-07-01
Kunz, Gary L.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 2531, 536 2533, 536 2534, C07H 2100
Patent
active
056440480
ABSTRACT:
A process for preparing phosphorothioate oligonucleotides utilizes S-(alkaryl or aryl) phosphorothioate compounds as intermediates suitable for use in the solution phase. A dinucleotide is prepared from a nucleoside intermediate that has been phosphitylated with an S-(alkaryl or aryl) alkyl phosphorothioate diester salt. The alkyl ester group is removed and the resulting nucleotide diester is reacted with a further nucleoside having a free 5'-hydroxyl group. Nucleotide units are linked together to yield compounds of the structure: ##STR1## where X is H, a first blocking group, a nucleoside, a nucleotide or an oligonucleotide; Y is H, a second blocking group, a nucleoside, a nucleotide or an oligonucleotide; R is an alkaryl or aryl group; n is an integer greater than 0; and Bx is a heterocyclic base. Deblocking of the S-alkaryl or S-aryl moiety yields a phosphorothioate oligonucleotide.
REFERENCES:
patent: 4415732 (1983-11-01), Caruthers et al.
patent: 5212295 (1993-05-01), Cook
Cohen, J.S., editor. Oligodeoxynucleotides: Anitsense Inhibitors of Gene Expression. Topics in Molecular and Structural Biology, vol. 12, 1989.
Brill, "Synthesis of Oligodeoxynucleoside Phosphorodithioates via Thiomidites", J. Am. Chem. Soc., 111:2321 (1989).
Brill, "Synthesis of Deoxydinucleoside Phosphorodithioates", J. Am. Chem. Soc., 113:3972 (1991).
Yau, "Synthesis of Dinucleoside and Dinucleotide Phosphorodithioates Via A Phosphotriester Approach", Tetrahedron Letters, 31:1953 (1990).
Miller, "A new approach to chemotherapy based on molecular biology and nucleic acid chemistry: Matagen (masking tape for gene expression)", Anti-cancer Drug Design, 2:117 (1987).
Daub, "Synthesis of Oligoribonucleotides Based on the Facile Cleavage of Methyl Phosphotriester Intermediates", J. Am. Chem. Soc., 98:3526, (1977).
Matteucci, "Solid Phase Synthesis of Oligodeoxyribonucleotides Utilizing the Phenylthio Group as a Phosphate Protecting Group", Bull. Chem. Soc., Jpn 60:1407 (1987).
Lisziewicz, et al., "Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells", Proc. Natl. Acad. Sci., USA, 91, 1994, 7942-7946.
Ramazeilles, et al., "Antisense phosphorothioate oligonucleotides: Selective killing of the intracellular parasite Leishmania amazonensis", Proc. Natl. Acad. Sci., 91, 1994, 7859-7863.
Soreq, et al., "Antisense olignucleotide inhibition of acetylcholinesterase gene expression induces progenitor cell expansion and suppresses hematopoietic apoptosis ex vivo", Proc. Natl. Acad. Sci., 91, 1994, 7907-7911.
ISIS Pharmaceuticals Inc.
Kunz Gary L.
LandOfFree
Process for preparing phosphorothioate oligonucleotides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for preparing phosphorothioate oligonucleotides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for preparing phosphorothioate oligonucleotides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-598694